HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph D Smith Selected Research

Endothelial Protein C Receptor

1/2022Plasmodium falciparum Parasite Lines Expressing DC8 and Group A PfEMP1 Bind to Brain, Intestinal, and Kidney Endothelial Cells.
1/2021Determinants of brain swelling in pediatric and adult cerebral malaria.
11/2017Linking EPCR-Binding PfEMP1 to Brain Swelling in Pediatric Cerebral Malaria.
1/2017EPCR and Malaria Severity: The Center of a Perfect Storm.
12/2016Interaction between Endothelial Protein C Receptor and Intercellular Adhesion Molecule 1 to Mediate Binding of Plasmodium falciparum-Infected Erythrocytes to Endothelial Cells.
6/2016Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomass.
12/2015Plasmodium falciparum adhesion domains linked to severe malaria differ in blockade of endothelial protein C receptor.
12/2015Diverse functional outcomes of Plasmodium falciparum ligation of EPCR: potential implications for malarial pathogenesis.
6/2013Severe malaria is associated with parasite binding to endothelial protein C receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph D Smith Research Topics

Disease

37Malaria
01/2022 - 03/2003
8Infections
11/2019 - 11/2004
8Cerebral Malaria
11/2017 - 09/2004
2Brain Edema (Cerebral Edema)
01/2021 - 11/2017
1Thrombocytopenia (Thrombopenia)
01/2021
1Communicable Diseases (Infectious Diseases)
10/2018
1Inflammation (Inflammations)
04/2012

Drug/Important Bio-Agent (IBA)

14VaccinesIBA
11/2019 - 03/2003
9Endothelial Protein C ReceptorIBA
01/2022 - 06/2013
9Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2003
9AntibodiesIBA
01/2019 - 07/2004
6Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2018 - 09/2007
4Surface Antigens (Surface Antigen)IBA
01/2019 - 09/2004
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2016 - 09/2004
3Membrane Proteins (Integral Membrane Proteins)IBA
02/2013 - 03/2007
3AntigensIBA
04/2012 - 12/2003
2artemisinin (artemisinine)IBA
10/2018 - 01/2016
2Antimalarials (Antimalarial Agents)IBA
10/2018 - 01/2016
2Protein CIBA
06/2016 - 12/2015
2LigandsIBA
06/2016 - 01/2005
1CytokinesIBA
01/2019
1Pharmaceutical PreparationsIBA
10/2018
1Virulence Factors (Pathogenicity Factors)IBA
06/2016
1ThrombinFDA Link
01/2016
1CoagulantsIBA
12/2015
1Plasmodium falciparum erythrocyte membrane protein 1IBA
03/2013
1Immunoglobulin G (IgG)IBA
03/2013
1Subunit VaccinesIBA
12/2009
1DisulfidesIBA
06/2009
1adhesion receptorIBA
09/2007
1Hyaluronic Acid (Hyaluronan)IBA
01/2004

Therapy/Procedure

3Therapeutics
10/2018 - 01/2016